7XE.F NIGHTINGALE HEALTH EO 1

Healthcare Health Care Technology Frankfurt Exchange
2.75 EUR
Close of Nov 11, 2026
0.6720 2.41
Market cap
EUR 112M
P/E
-
P/B
2.55x
ROE
-37.9%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Jun 2026.

Is 7XE.F undervalued?

Graham number

The Graham number of NIGHTINGALE HEALTH EO 1 cannot be estimated reliably (it needs positive earnings and book value).

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

NIGHTINGALE HEALTH EO 1 fundamental analysis

No fundamental analysis for NIGHTINGALE HEALTH EO 1 yet.

NIGHTINGALE HEALTH EO 1 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About NIGHTINGALE HEALTH EO 1

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, Europe, the Middle East, Africa, AMER, and the Asia-Pacific. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely, as well as multiomics analysis services. It provides its services to research programs, universities, and healthc…

Full company profile